ACPharm Queensland Pty Ltd
Paid five TGA infringement notices totalling A$99,000 over alleged medicinal cannabis and unapproved-goods ads
This entry is about Australia — not the country you picked in the header.
According to Therapeutic Goods Administration, Nov 3, 2025 · Read the source
Summary
The Therapeutic Goods Administration (TGA) said on 3 November 2025 that it had issued five infringement notices totalling A$99,000 to ACPharm Queensland Pty Ltd for alleged unlawful advertising of therapeutic goods under the Therapeutic Goods Act 1989. According to the TGA, the company paid the notices in October 2025.
The TGA alleges that ACPharm Queensland advertised medicinal cannabis, a prescription-only medicine that may not be advertised to consumers, and other therapeutic goods not included in the Australian Register of Therapeutic Goods. It also alleges that the advertising promoted a therapeutic good for serious diseases, conditions or disorders, which requires TGA approval or permission. Payment of an infringement notice is not an admission of liability.
What the source found
- Five infringement notices totalling A$99,000 issued, per the TGA release of 3 November 2025
- Notices paid in October 2025
- Alleged advertising of medicinal cannabis and of therapeutic goods not on the ARTG
- Alleged restricted or prohibited representations about serious conditions
Products named
- medicinal cannabis (prescription-only)
- unapproved therapeutic goods
Timeline
Infringement notices paid
TGA publishes the infringement notices
Sources
- Regulator
Therapeutic Goods Administration · Nov 3, 2025
ACPharm Queensland issued infringement notices for alleged unlawful advertising of therapeutic goods
Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.
Status notes
Resolved by payment of infringement notices; status kept 'official-action' because the TGA record is the action itself.
Comments
No comments yet.
Related entries
The full Red ListTell us what happened
Every report is read by a person. You don’t need to prove anything, and we never publish your name.
- A moderator reads your report and checks the link against the Red List and our seller records.
- We look for an authoritative source — a regulator, court, police or consumer-protection finding.
- When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.